Sinemet 25/250 mg – 20 Tablets
Sinemet combines levodopa and carbidopa to effectively manage motor symptoms of Parkinson’s disease. Levodopa converts to dopamine in the brain to improve movement control, while carbidopa enhances its efficacy and minimizes side effects.
Key Ingredients & Their Benefits
-
Levodopa 250 mg – Converts to dopamine in the brain, relieving tremors, stiffness, and slowness of movementÂ
-
Carbidopa 25 mg – Prevents premature breakdown of levodopa, increasing brain availability and reducing nauseaÂ
Key Benefits
-
Targets core Parkinson’s symptoms including rigidity, tremors, and bradykinesia
-
Enables effective dosing with reduced gastrointestinal side effectsÂ
-
Allows faster therapeutic response compared to levodopa aloneÂ
How to Use
Dosage is individualized; typically start with one tablet three to four times daily, adjusting gradually. Always follow medical advice and titrate under physician supervisionÂ
Who It’s For
-
Adults diagnosed with Parkinson’s disease managing motor symptoms
-
Patients transitioning from levodopa alone to enhanced therapy
-
Those requiring controlled dopamine levels with fewer side effects
Expected Results
-
Visible symptom relief (e.g., better movement, reduced stiffness) often within days
-
Stabilized motor function and daily activity support
-
Improved symptom control with reduced nausea compared to levodopa alone
Brand: MSD
Made in Netherlands
